| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |